August 21, 2017 10:17 AM ET

Biotechnology

Company Overview of Aileron Therapeutics, Inc.

Key Executives for Aileron Therapeutics, Inc.

NameBoard RelationshipsTitleAge
Joseph A. Yanchik III, Esq.13 RelationshipsFounder, President, CEO & Director53
Huw M. Nash Ph.D.No RelationshipsCo-Founder--
Donald V. Dougherty CPA, CFANo RelationshipsSenior VP & CFO58
Kira A. Nelson CPANo RelationshipsVice President of Finance & Operations48
Manuel C. Aivado M.D., Ph.D.No RelationshipsChief Scientific Officer, Chief Medical Officer & Senior VP47

Aileron Therapeutics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Scott Bancroft Kapnick 20 RelationshipsHPS Investment Partners, LLC58
Joseph A. Yanchik III, Esq. 13 RelationshipsAileron Therapeutics, Inc.53
Caleb Winder 26 RelationshipsBiotechonomy45
Reinhard J. Ambros Ph.D. 34 RelationshipsNovartis Venture Funds62
Armen B. Shanafelt Ph.D. 63 RelationshipsLilly Ventures Management Company, LLC58
View All Board Members

Aileron Therapeutics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Caleb Winder26 Relationships3 Executives
Compensation Committee Ph.D.Reinhard J. Ambros34 Relationships3 Executives
Nominating Committee Ph.D.Armen B. Shanafelt63 Relationships3 Executives
Corporate Governance Committee Ph.D.Armen B. Shanafelt63 Relationships3 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary$425.2K
425.2K
387.5K
Bonus$239.2K
239.2K
237.8K
Total Short Term Compensation
Not meaningful
Total Value of Options$664.4K
664.4K
18.6M
Compensation as of Fiscal Year 2016
Aileron Therapeutics, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Prima BioMed Ltd. Appoints Grant Chamberlain as Non-Executive Director
August 20, 2017 10:20 PM ET
Cellectar Biosciences, Inc. Announces Management Changes
August 18, 2017 9:00 PM ET
Isofol Medical AB (publ) Appoints Sven Erickson as Chief Commercial Officer
August 18, 2017 6:32 PM ET
Kane Biotech Inc. Announces Resignation of Sarah Prichard as Director
August 18, 2017 11:12 AM ET
RHS Limited Appoints Alwin Hui as Chief Commercial Officer
August 18, 2017 3:43 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Aileron Therapeutics, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.